BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

MGI Tech and JCBio Forge Landmark Alliance to Launch DCS Lab Project in South Korea

MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and JCBio Co., Ltd. ("JCB...

September 01, 2025 | News

ACROBiosystems and South Korea’s DAAN Biotherapeutics Sign Strategic MOU to Advance Precision Immuno-Oncology

ACROBiosystems, a global biotechnology company dedicated to accelerating the drug development process through innovative tools and solutions, announced tha...

August 29, 2025 | News

Celaid and AGC Partner in Japan to Advance Scalable Expansion of iPSC-Derived Blood Stem Cells

Celaid Therapeutics Inc. ("Celaid") have executed a collaborative research agreement with AGC Inc. ("AGC") to advance iPS cell-derived hematopoietic stem a...

August 29, 2025 | News

Actinogen Confirms Commercial Tablet Formulation Of Xanamem Achieves Therapeutic Blood Levels

Actinogen Medical Limited (ASX: ACW) announces that a recent trial designed to confirm therapeutic blood levels of the intended commercial tablet form...

August 28, 2025 | News

Hope Biosciences Receives First RMAT Designation For Stem Cell Therapy In Multiple Sclerosis

Leading U.S. stem cell banking and cellular therapeutic manufacturer Hope Biosciences announces the U.S. Food and Drug Administration (FDA) has g...

August 28, 2025 | News

Avance Clinical Guides 710 Emerging Biotechs Through Critical Early-Phase Milestones

Avance Clinical, a partner for biotechs providing global contract research organization services, has now guided 710 emerging biotechs through critical cli...

August 28, 2025 | News

Neusoft Medical Secures China’s First Approval For Photon-Counting CT With NeuViz P10

Neusoft Medical Systems announced that its NeuViz P10 photon-counting CT has received market approval from China's National Medical Product...

August 28, 2025 | News

Akeso Reports Positive Phase 3 Results For Gumokimab In Ankylosing Spondylitis And Manfidokimab In Atopic Dermatitis

Akeso Inc. announced positive results from its Phase 3 clinical trial of gumokimab (AK111), a novel, fully human anti-IL-17A monoclonal antibod...

August 26, 2025 | News

Lighthouse Pharma Secures $49.2M NIH Grant to Launch Phase 2 Alzheimer’s Trial in the United States

Groundbreaking Clinical Trial to Enroll 300 Patients in Double-Blind, Placebo-Controlled Study of Lysine-Gingipain Inhibitor Lighthouse Pharmaceuticals, a...

August 25, 2025 | News

SMSbiotech Launches First-in-Human Trial of Small Mobile Stem Cells for COPD in Australia

SMSbiotech, a San Diego–based leader in regenerative medicine, announced the initiation of its first-in-human Phase 1 clinical trial for C...

August 22, 2025 | News

Japan’s ARC Therapies Initiates Research on Novel Gut Microbe YB328 for Cancer Immunotherapy

ARC Therapies Inc. (Head Office: Shinjuku, Tokyo; President & CEO: Rami Suzuki), a certified startup from the National Cancer Cente...

August 21, 2025 | News

Akeso Doses First Patient in Phase III COMPASSION-33 Trial of Cadonilimab for Perioperative Gastric Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the enrollment and dosing of the first patient in the pivotal Phase III clinical trial (AK104-31...

August 21, 2025 | News

LabConnect Launches LabConnector™ to Transform Clinical Trial Data Management

LabConnect, LLC, a global leader in central laboratory services for clinical trials, announced the launch of LabConnector™, a powerful new techn...

August 20, 2025 | News

Mabwell Secures FDA IND Clearance for CDH17-Targeting ADC 7MW4911 in Advanced GI Cancers

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its self-developed CDH17-targeting ADC (R&D cod...

August 20, 2025 | News

Stay Connected